News by Subject Medicine & Health

What The Study Did: In this analysis of the 2015 U.S. Transgender Survey, gender-affirming hair removal procedures were associated with lower odds of past-month severe psychological distress, past-year smoking and past-year suicidal ideation.

Combining chemotherapy with a BRAF oncogene inhibitor proves effective at treating this disease. The study, published in the journal Oncogene, was led by researchers from the Hospital del Mar Medical Research Institute, Hospital del Mar and CIBERONC. This alternative paves the way towards a new approach for patients affected by this type of tumour, which has no cure in the most advanced stages or cases of relapse.

About one in five Danes react to contact allergens, but some patients develop rashes and itching much faster than others. Previously the scientists were unable to explain why, but now researchers from the University of Copenhagen have outlined an entire new subgroup of allergic reactions which explains these early skin reactions. The new knowledge is vital to understanding the disease mechanisms in contact allergy.

A skin pigmentation mechanism that can darken the color of human skin as a natural defense against ultraviolet (UV)-associated cancers has been discovered by scientists at Massachusetts General Hospital (MGH).

What The Study Did: National survey data were used to estimate how common psoriasis is among adults in the United States and how this has changed since 2003.

Researchers from Tokyo Medical and Dental University (TMDU) have designed a deep learning-based system that accurately identifies individual skin stem cells grown under artificial conditions and tracks their motion. Using this system to perform quality control of stem cell cultures could improve the speed and efficiency of growing skin grafts for use in regenerative medicine and may also be useful for other types of stem cell cultures.

Skin problems after a first mRNA COVID-19 vaccine dose occurred in 1.9% of surveyed employees from hospital system Mass General Brigham. Among employees who experienced a skin reaction to the first dose, 83% had no recurrence of symptoms following the second dose.

What The Study Did: Hospital employees were surveyed about symptoms such as a rash, itching, hives or swelling around the face after receiving a messenger RNA COVID-19 vaccine.